Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.47 |
| ▸ | RXRB | P28702 | 3/20 | 0.47 |
| ▸ | CYP26B1 | Q9NR63 | 3/20 | 0.46 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 4/20 | 0.45 |
| ▸ | RARB | P10826 | 6/20 | 0.44 |
| ▸ | RARG | P13631 | 6/20 | 0.44 |
| ▸ | RARA | P10276 | 5/20 | 0.44 |
| ▸ | RXRG | P48443 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8100914 | 0.91 | RXRA (0.48) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| Hydrochloric Acid SCHEMBL8102611 | 0.90 | RXRA (0.47) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL8102607 | 0.89 | RXRA (0.49) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL8555469 | 0.82 | RXRA (0.49) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL8103031 | 0.80 | RXRA (0.57) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL6145801 | 0.77 | CYP26A1 (0.48) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL10968190 | 0.77 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL8556266 | 0.77 | RARG (0.45) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL8681345 | 0.76 | RXRA (0.48) | RXRARXRBCYP26B1CYP26A1CYP3A4 | |
| SCHEMBL11521962 | 0.76 | LMNA (0.54) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6051243-A | USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) | 2000-04-18 | — | — | US | disclosed |
| US-5709867-A | TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1998-01-20 | — | — | US | disclosed |